Purpose: To investigate age-related changes in the locus ceruleus (LC) in healthy subjects using neuromelanin magnetic resonance (MR) imaging at 3 Tesla.
Introduction
The locus ceruleus (LC) is a small blue-black nucleus on the ‰oor of the fourth ventricle that comprises noradrenergic neurons containing neuromelanin, a byproduct of monoamine synthesis. 1, 2 Although neuromelanin is said to have paramagnetic T1 shortening eŠects when combined with metals, 3, 4 the LC has been an invisible nucleus on conventional magnetic resonance (MR) imaging. Recently, we reported that the LC can be identiˆed using neuromelanin MR imaging at 3 Tesla (3T) and that it is obscured in Parkinson's disease (PD), in which the LC is selectively aŠected. 5 However, the age-dependent changes in LC signal on neuromelanin MR imaging have not been determined. In this study, we quantitatively examined the signal intensity of the LC in young to elderly adults to elucidate whether the neuromelanin-generated contrast depends on age-related changes in neuromelanin concentration, which has been pathologically proven. [6] [7] [8] 
Materials and Methods
We examined 64 healthy volunteers (28 men, 36 women) 23 to 80 years old (mean age 50.3) using a superconductive 3T MR scanner (Signa VH W i, GE, Milwaukee, Wisconsin, USA). Pulse sequence was T1-weighted fast spin-echo (FSE), 600 W 14 repetition time W eŠective echo time (TR W TE), 2-echo train length, 2.5-mm section thickness with 1-mm intersection gaps, matrix size 512×320, 220-mmˆeld of view (FOV; pixel size 0.43×0.69 mm), and acquisition time 12 min, as previously described. 5 The sections were in the oblique axial direction perpendicular to the fourth ventricle ‰oor and covered from the posterior commissure to the pontine inferior border, with one slice at the inferior edge of the inferior colliculus. We also obtained protondensity and T2-weighted FSE images (3000 W 16, 96; 8-echo train length) with the same parameters to exclude pathological lesions in the brain stem. All examinations were performed after approval of the institutional review board. Written informed consent was obtained from all subjects.
One of the authors, who was blinded, measured the signal intensity of the LC at 7 mm below the In all age ranges, we recognized symmetric high signal spots in the upper pontine tegmentum, suggesting the existence of neuromelanin at the LC (arrows). The signal intensity appears to be relatively low in both young and elderly subjects relatively high in middle-aged subjects. The contrast ratio (CR) of the LC was calculated as (SLC-SPT) W SPT, where SLC is the signal intensity of the LC and SPT is the signal intensity of the pontine tegmentum. Polynomial regression analysis with quadratic curveˆtting and alpha level of 0.05 was performed to determine whether the contrast ratio showed age-dependent changes.
Results
On axial neuromelanin-sensitive images of healthy volunteers of all age groups, we recognized symmetric spots of high signal in the upper pontine tegmentum just anterolateral to the fourth ventricle ‰oor (Fig. 1) . This corresponds well with the location of the LC, as previously reported. 5 Our quantitative analysis revealed that the average contrast ratio of the LC in the 64 healthy subjects was 10 Polynomial regression analysis revealed increased contrast ratio of the LC up to the 40 s and 50 s that gradually decreased signiˆcantly in the 60 s and 70 s ( P＝0.01); the data can beˆtted to a quadratic curve: y＝0.58x-0.0055x 2 -3.3 with a multiple correlation coe‹cient of 0.38 (Fig. 2) .
The contrast ratios of men were 10.53±3.45 (n＝ 28, 26 to 80 years, mean 52.3) and of women were 11.10±3.78 (n＝36, 23 to 75 years, mean 48.7), with no signiˆcant diŠerence between them.
Discussion
Recently, we visualized neuromelanin-containing nuclei, the LC, and the substantia nigra pars compacta (SNc) using T1-weighted FSE at 3T, presuma- bly permitted by synergic eŠects from high spatial resolution, signal attenuation of the brain tissue from T1 prolongation, and FSE-related magnetization transfer eŠect. 5 We demonstrated reduced signal intensity of these structures in patients with Parkinson's disease patients compared with agematched healthy controls. 5 In this study, we also elucidated an age-related diŠerence in signal intensity of the LC among healthy subjects. To the best of our knowledge, this is theˆrst report concerning in vivo imaging of age-dependent alteration in the LC.
Histological studies have revealed that the number of adrenergic neurons and amount of intraneuronal neuromelanin in the LC both increase until age 60 and then tend to decrease, 6, 7 although in some study reports disagree. 8 In this study, the contrast ratios of the LC tended to be relatively low in young and elderly subjects and relatively high in middle-aged subjects. This agerelated tendency was statistically signiˆcant and can beˆtted to an upwardly convex quadratic curve. This result corresponded well with agerelated changes reported in previous histological studies, 6, 7 suggesting that LC signals on neuromelanin MR imaging re‰ect changes in neuronal number and intracellular neuromelanin concentration that occur during aging. It also indicates that we should consider patient age when evaluating for signal abnormalities in the LC.
Pathologically, the LC has been known to be aŠected in degenerative diseases, such as Parkinson's and Alzheimer's, [9] [10] [11] as well as in psychiatric disorders, such as depression and schizophrenia. [12] [13] [14] [15] In Parkinson's and Alzheimer's diseases, neurons are lost and intraneuronal neuromelanin is diminished. [9] [10] [11] On the other hand, in depression and schizophrenia, subtle changes were observed in neuronal number or size and in enzyme activities that suggested dysfunction of the noradrenergic system. [12] [13] [14] [15] We believe that neuromelanin MR imaging has the potential to detect organic or functional changes in the LC in the above-cited disorders as a reduction in the neuromelaninproduced contrast from decreased cell number and W or intracellular neuromelanin concentration. 5 However, signal changes that occur during pathological conditions should be carefully evaluated by considering age-dependent signal ‰uctuations.
One limitation of this study is the absence of data in children, teenagers, and elderly over 80 years, resulting mainly from di‹culties recruiting healthy volunteers of these ages. We speculate that the signal intensity of the LC in these age ranges is relatively low 6, 7 and may be roughly estimated by extrapolation of the quadratic curve, which we obtained. Another limitation is the pulse sequence we used. The T1-weighted FSE sequence used for neuromelanin imaging appears to have insu‹cient spatial resolution in both the in-plane and slice directions to avoid errors from partial volume eŠects when measuring the signal intensity of the LC. Uneven signal from the inhomogeneity of a local magneticˆeld (B1) is remarkable, 16 which may also aŠect the quantitative values of the LC. To overcome this limitation, we need a new sophisticated sequence with 3-dimensional acquisition capability and less sensitivity to B1 inhomogeneity.
In this study, we did not measure the SNc because of the possible in‰uence of intraneuronal iron that can accelerate neuromelanin-related T1 relaxation. 17, 18 Dopaminergic neurons in the SNc are well known to contain abundant iron (approximately 20 mg W 100 g tissue) that increases with aging. 18 Thus, because the iron concentration within the SNc can strongly aŠect the neuromelanin-generated T1 contrast, it may mask agerelated changes, particularly in elderly subjects. Thus, iron-compensationW normalization techniques are needed to quantitatively evaluate neuromelanin within the SNc, which we are currently investigating.
The biological implications of the age-related alteration of neuromelanin remain unknown. Although little has been elucidated regarding the physiological roles of neuromelanin, it is speculated that neuromelanin can attenuate neuronal damage by binding with metals or mediating intracellular oxidation. 19 Thus, the age-related changes may re‰ect not only changes in noradrenergic activity but also reinforcement and degradation of the neuronal protection mechanism during aging.
Conclusion
Using neuromelanin imaging at 3T, we visualized the LC in normal subjects aged 23 to 80 years, and its signal intensity showed ‰uctuations that correlated with age-dependent changes in the neuromelanin concentration. It appears that neuromelanin MR imaging is capable of assessing degenerative or functional changes in the LC; however, age-related signal alterations should be considered when evaluating abnormalities in disorders aŠect-ing the LC.
